{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:42:29Z","timestamp":1793965349706,"version":"4.8.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To investigate the relationship between intraretinal hyperreflective foci (HRF) and visual function in intermediate age-related macular degeneration (iAMD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Retrospective, cross-sectional study. iAMD patients underwent spectral domain optical coherence tomography (SD-OCT) imaging and vision function testing: normal luminance best corrected visual acuity (VA), low luminance VA (LLVA), quantitative contrast sensitivity function (qCSF), low luminance qCSF (LLqCSF), and mesopic microperimetry. Each OCT volume was graded for the presence and number of HRF. Each HRF was graded for: separation from the retinal pigment epithelium (RPE), above drusen, and shadowing. Central drusen volume was calculated by the built-in functionality of the commercial OCT software after manual segmentation of the RPE and Bruch\u2019s membrane.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>HRF group: 11 eyes; 9 patients; mean age 75.7 years. No-HRF group: 11 eyes; 10 patients; mean age 74.8 years. In linear mixed effect model adjusting for cube-root transformed drusen volume, HRF group showed statistically significant worse VA, LLVA, LLqCSF, and microperimetry. HRF group showed worse cone function, as measured by our pre-defined multicomponent endpoint, incorporating LLVA, LLqCSF and microperimetry (p\u2009=\u20090.018). For eyes with HRF, # of HRF did not correlate with any functional measures; however, % of HRF separated from RPE and # of HRF that created shadowing were statistically associated with low luminance deficit (LLD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The association between the presence of HRF and worse cone visual function supports the hypothesis that eyes with HRF have more advanced disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40942-023-00461-0","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T10:03:19Z","timestamp":1680861799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Correlation between hyperreflective foci and visual function testing in eyes with intermediate age-related macular degeneration"],"prefix":"10.1186","volume":"9","author":[{"given":"T. Y. Alvin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl G.","family":"Csaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,7]]},"reference":[{"issue":"15","key":"461_CR1","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1001\/jama.291.15.1900","volume":"291","author":"NM Bressler","year":"2004","unstructured":"Bressler NM. Age-related macular degeneration is the leading cause of blindness. JAMA. 2004;291(15):1900\u20131.","journal-title":"JAMA"},{"issue":"11","key":"461_CR2","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1001\/archopht.123.11.1570","volume":"123","author":"FL Ferris","year":"2005","unstructured":"Ferris FL, Davis MD, Clemons TE, et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005;123(11):1570\u20134.","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"461_CR3","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.ophtha.2019.05.016","volume":"126","author":"M Nassisi","year":"2019","unstructured":"Nassisi M, Lei J, Abdelfattah NS, et al. OCT risk factors for development of late age-related Macular Degeneration in the fellow eyes of patients enrolled in the HARBOR Study. Ophthalmology. 2019;126(12):1667\u201374.","journal-title":"Ophthalmology"},{"key":"461_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ajo.2018.02.012","volume":"189","author":"KJ Cocce","year":"2018","unstructured":"Cocce KJ, Stinnett SS, Luhmann UFO, et al. Visual function Metrics in Early and Intermediate Dry Age-related Macular Degeneration for Use as Clinical Trial Endpoints. Am J Ophthalmol. 2018;189:127\u201338.","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"461_CR5","doi-asserted-by":"publisher","first-page":"7310","DOI":"10.1167\/iovs.11-8649","volume":"53","author":"MC Puell","year":"2012","unstructured":"Puell MC, Barrio AR, Palomo-Alvarez C, G\u00f3mez-Sanz FJ, Clement-Corral A, P\u00e9rez-Carrasco MJ. Impaired mesopic visual acuity in eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci. 2012;53(11):7310\u20134.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"461_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1001\/jamaophthalmol.2014.5963","volume":"133","author":"Z Wu","year":"2015","unstructured":"Wu Z, Ayton LN, Luu CD, Guymer RH. Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration. JAMA Ophthalmol. 2015;133(4):442\u20138.","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"461_CR7","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ophtha.2018.09.015","volume":"126","author":"RH Guymer","year":"2019","unstructured":"Guymer RH, Wu Z, Hodgson LAB, et al. Subthreshold nanosecond laser intervention in Age-Related Macular Degeneration: the LEAD Randomized Controlled Clinical Trial. Ophthalmology. 2019;126(6):829\u201338.","journal-title":"Ophthalmology"},{"issue":"7","key":"461_CR8","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1097\/IAE.0000000000001454","volume":"37","author":"D Neely","year":"2017","unstructured":"Neely D, Zarubina AV, Clark ME, et al. Association between visual function and subretinal drusenoid deposits in normal and early age-related macular degeneration eyes. Retina. 2017;37(7):1329\u201336.","journal-title":"Retina"},{"issue":"4","key":"461_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1167\/tvst.9.4.10","volume":"9","author":"WC Ou","year":"2020","unstructured":"Ou WC, Denlar RA, Csaky KG. The relationship between Central Drusen volume and low-luminance deficit in Age-Related Macular Degeneration. Transl Vis Sci Technol. 2020;9(4):10.","journal-title":"Transl Vis Sci Technol"},{"key":"461_CR10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ajo.2021.01.017","volume":"226","author":"WC Ou","year":"2021","unstructured":"Ou WC, Lesmes LA, Christie AH, Denlar RA, Csaky KG. Normal- and low-luminance automated quantitative contrast Sensitivity Assessment in eyes with age-related Macular Degeneration. Am J Ophthalmol. 2021;226:148\u201355. https:\/\/doi.org\/10.1016\/j.ajo.2021.01.017.","journal-title":"Am J Ophthalmol"},{"key":"461_CR11","unstructured":"Pelli DG, Robson JG, Wilkins JAJ. The design of a new letter chart for measuring contrast sensitivity. In: Clinical Vision Sciences.; 1988. Accessed December 29, 2021. http:\/\/citeseerx.ist.psu.edu\/viewdoc\/summary?doi=10.1.1.321.5971"},{"issue":"6","key":"461_CR12","doi-asserted-by":"publisher","first-page":"BIO277","DOI":"10.1167\/iovs.17-21863","volume":"58","author":"KA Joltikov","year":"2017","unstructured":"Joltikov KA, de Castro VM, Davila JR, et al. Multidimensional functional and structural evaluation reveals Neuroretinal Impairment in Early Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2017;58(6):BIO277\u201390.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"461_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12886-018-0982-0","volume":"18","author":"BO Alahmadi","year":"2018","unstructured":"Alahmadi BO, Omari AA, Abalem MF, et al. Contrast sensitivity deficits in patients with mutation-proven inherited retinal degenerations. BMC Ophthalmol. 2018;18(1):313.","journal-title":"BMC Ophthalmol"},{"issue":"11","key":"461_CR14","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.oret.2020.05.001","volume":"4","author":"BS Echols","year":"2020","unstructured":"Echols BS, Clark ME, Swain TA, et al. Hyperreflective Foci and Specks are Associated with delayed rod-mediated Dark Adaptation in Nonneovascular Age-Related Macular Degeneration. Ophthalmol Retina. 2020;4(11):1059\u201368. https:\/\/doi.org\/10.1016\/j.oret.2020.05.001.","journal-title":"Ophthalmol Retina"},{"issue":"28","key":"461_CR15","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1002\/sim.7386","volume":"36","author":"AJ Sankoh","year":"2017","unstructured":"Sankoh AJ, Li H, D\u2019Agostino RB, Sr. Composite and multicomponent end points in clinical trials. Stat Med. 2017;36(28):4437\u201340.","journal-title":"Stat Med"},{"issue":"4","key":"461_CR16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","volume":"120","author":"FL Ferris","year":"2013","unstructured":"Ferris FL, Wilkinson CP, Bird A, et al. Clinical classification of Age-related Macular Degeneration. Ophthalmology. 2013;120(4):844\u201351. https:\/\/doi.org\/10.1016\/j.ophtha.2012.10.036.","journal-title":"Ophthalmology"},{"issue":"4","key":"461_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","volume":"125","author":"SR Sadda","year":"2018","unstructured":"Sadda SR, Guymer R, Holz FG, et al. Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: classification of Atrophy Report 3. Ophthalmology. 2018;125(4):537\u201348.","journal-title":"Ophthalmology"},{"issue":"3","key":"461_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1167\/10.3.17","volume":"10","author":"LA Lesmes","year":"2010","unstructured":"Lesmes LA, Lu ZL, Baek J, Albright TD. Bayesian adaptive estimation of the contrast sensitivity function: the quick CSF method. J Vis. 2010;10(3):171\u201321.","journal-title":"J Vis"},{"issue":"8","key":"461_CR19","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00417-017-3693-y","volume":"255","author":"J Lei","year":"2017","unstructured":"Lei J, Balasubramanian S, Abdelfattah NS, Nittala MG, Sadda SR. Proposal of a simple optical coherence tomography-based scoring system for progression of age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2017;255(8):1551\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"461_CR20","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1097\/IAE.0000000000002182","volume":"38","author":"M Li","year":"2018","unstructured":"Li M, Huisingh C, Messinger J, et al. HISTOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION: a Multilayer Approach. Retina. 2018;38(10):1937\u201353.","journal-title":"Retina"},{"issue":"8","key":"461_CR21","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1167\/iovs.18-24143","volume":"59","author":"M Nassisi","year":"2018","unstructured":"Nassisi M, Fan W, Shi Y, et al. Quantity of Intraretinal Hyperreflective Foci in patients with Intermediate Age-Related Macular Degeneration correlates with 1-Year progression. Invest Ophthalmol Vis Sci. 2018;59(8):3431\u20139.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-023-00461-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-023-00461-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-023-00461-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T10:08:01Z","timestamp":1680862081000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-023-00461-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["461"],"URL":"https:\/\/doi.org\/10.1186\/s40942-023-00461-0","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,7]]},"assertion":[{"value":"28 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was a retrospective cross-sectional study that was approved by the University of Texas Southwestern (Dallas, TX) institutional review board. It adhered to the Declaration of Helsinki and the Health Insurance Portability and Accountability Act. All study participants provided written informed consent, and were seen at the Retina Foundation of the Southwest (Dallas, TX).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial interests to report. The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"24"}}